Maturation of mucosal immune responses and influence of maternal antibodies

被引:11
作者
Jonsdottir, I. [1 ]
机构
[1] Univ Iceland, Landspitali Univ Hosp, Dept Immunol, IS-101 Reykjavik, Iceland
[2] CODE Genet, IS-101 Reykjavik, Iceland
关键词
mucosal immune system; IgA; vaccine; mucosal adjuvant; neonate; maternal antibodies;
D O I
10.1016/j.jcpa.2007.04.007
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
The mucosae represent the primary point of contact between the major respiratory and enteric pathogens and the innate and adaptive immune response. The microanatomy and function of the mucosal immune system is now well-characterized, in particular the major effector mechanism that involves the production and translocation of secretory immunoglobulin A (IgA). Mucosal delivery of antigen has the potential to induce potent local and systemic immunity, although such responses may differ between neonatal, infant and adult mice. In younger animals mucosal immune responses are Th2 biased, whereas in adults there is a broader Th1 and Th2 responsiveness. There is much interest in the development of mucosally delivered vaccines which can be tailored to enhance Th1 immunity or to avoid potential interference from maternally derived antibodies (MDA). Accordingly, a range of mucosal adjuvants (particularly those derived from bacteria) has been tested, and live recombinant vectored vaccines may also be effectively delivered by this route. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S20 / S26
页数:7
相关论文
共 37 条
[1]
ADARNA BC, 2004, THESIS U ICELAND
[2]
The advantage of mucosal immunization for polysaccharide-specific memory responses in early life [J].
Bjarnarson, SP ;
Jakobsen, H ;
Del Giudice, G ;
Trannoy, E ;
Siegrist, CA ;
Jonsdottir, I .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (04) :1037-1045
[3]
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[4]
Let's go mucosal: communication on slippery ground [J].
Brandtzaeg, P ;
Pabst, R .
TRENDS IN IMMUNOLOGY, 2004, 25 (11) :570-577
[5]
BRYNJOLFSSON SF, 2006, P 16 EUR C IMM, P380
[6]
Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers [J].
Capozzo, AVE ;
Cuberos, L ;
Levine, MM ;
Pasetti, MF .
INFECTION AND IMMUNITY, 2004, 72 (08) :4637-4646
[7]
Cutts FT, 2005, LANCET, V366, P28
[8]
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial [J].
Cutts, FT ;
Zaman, SMA ;
Enwere, G ;
Jaffar, S ;
Levine, OS ;
Okoko, JB ;
Oluwalana, C ;
Vaughan, A ;
Obaro, SK ;
Leach, A ;
McAdam, KP ;
Biney, E ;
Saaka, M ;
Onwuchekwa, U ;
Yallop, F ;
Pierce, NF ;
Greenwood, BM ;
Adegbola, RA .
LANCET, 2005, 365 (9465) :1139-1146
[9]
Mucosal delivery of vaccine antigens and its advantages in pediatrics [J].
De Magistnis, MT .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (01) :52-67
[10]
Nasal-associated lymphoid tissue (NALT):: frequency and localization in young children [J].
Debertin, AS ;
Tschernig, T ;
Tönjes, H ;
Kleemann, WJ ;
Tröger, HD ;
Pabst, R .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 134 (03) :503-507